Your browser doesn't support javascript.
loading
Regulation of Hepatic Metabolism, Recent Advances, and Future Perspectives.
Sharabi, Kfir; Tavares, Clint D J; Puigserver, Pere.
Afiliación
  • Sharabi K; Department of Cancer Biology, Dana-Farber Cancer Institute and Department of Cell Biology, Harvard Medical School, 450 Brookline Av. LC-6219H, Boston, MA, 02215, USA. kfir_sharabi@dfci.harvard.edu.
  • Tavares CDJ; Department of Cancer Biology, Dana-Farber Cancer Institute and Department of Cell Biology, Harvard Medical School, 450 Brookline Av. LC-6219H, Boston, MA, 02215, USA.
  • Puigserver P; Department of Cancer Biology, Dana-Farber Cancer Institute and Department of Cell Biology, Harvard Medical School, 450 Brookline Av. LC-6219H, Boston, MA, 02215, USA. pere_puigserver@dfci.harvard.edu.
Curr Diab Rep ; 19(10): 98, 2019 09 07.
Article en En | MEDLINE | ID: mdl-31494755
PURPOSE OF REVIEW: The purpose of this review is to provide a brief summary of recent advances in our understanding of liver metabolism. The critical role of the liver in controlling whole-body energy homeostasis makes such understanding crucial to efficiently design new treatments for metabolic syndrome diseases, including type 2 diabetes (T2D). RECENT FINDINGS: Significant advances have been made regarding our understanding of the direct and indirect effects of insulin on hepatic metabolism and the communication between the liver and other tissues. Moreover, the catabolic functions of glucagon, as well as the importance of hepatic redox status for the regulation of glucose production, are emerging as potential targets to reduce hyperglycemia. A resolution to the long-standing question "insulin suppression of hepatic glucose production, direct or indirect effect?" is starting to emerge. New advances in our understanding of important fasting-induced hepatic metabolic fluxes may help design better therapies for T2D.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Metabolismo Energético / Glucosa / Hipoglucemiantes / Insulina / Hígado Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Curr Diab Rep Asunto de la revista: ENDOCRINOLOGIA Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Metabolismo Energético / Glucosa / Hipoglucemiantes / Insulina / Hígado Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Curr Diab Rep Asunto de la revista: ENDOCRINOLOGIA Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos